AR071736A1 - PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF VARIOUS ANTISPASMODIC AGENTS AND AN NON-STEROID ANTI-INFLAMMATORY AGENT, USEFUL FOR THE CONTROL AND TREATMENT OF RENAL COLICO AND INFLAMMATION - Google Patents

PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF VARIOUS ANTISPASMODIC AGENTS AND AN NON-STEROID ANTI-INFLAMMATORY AGENT, USEFUL FOR THE CONTROL AND TREATMENT OF RENAL COLICO AND INFLAMMATION

Info

Publication number
AR071736A1
AR071736A1 ARP080105130A ARP080105130A AR071736A1 AR 071736 A1 AR071736 A1 AR 071736A1 AR P080105130 A ARP080105130 A AR P080105130A AR P080105130 A ARP080105130 A AR P080105130A AR 071736 A1 AR071736 A1 AR 071736A1
Authority
AR
Argentina
Prior art keywords
renal
control
useful
pharmaceutical composition
treatment
Prior art date
Application number
ARP080105130A
Other languages
Spanish (es)
Inventor
Murillo Josefina Santos
Ochoa Victor Guillermo Alvarez
Armenta Maria Elena Garcia
Original Assignee
World Trade Imp Exp Wtie A G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by World Trade Imp Exp Wtie A G filed Critical World Trade Imp Exp Wtie A G
Publication of AR071736A1 publication Critical patent/AR071736A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente se refiere a una composicion farmaceutica en forma de c psulas o tabletas compuesta por la combinacion sinergica de diversos agentes antiespasmodicos, como son los principios activos: Floroglucinol y Trimetilfluoroglucinol y un agente antiinflamatorio no esteroideo, como lo es el principio activo: Meloxicam, adem s de excipientes farmaceuticamente aceptables, mismos que se encuentran formulados en una sola unidad de dosis para ser administrada por via oral, util para el control y tratamiento del colico renal y la inflamacion ocasionada por litiasis, logrando adem s un eficaz control del dolor adem s de conseguir que se conserve sana la funcion renal suprimiendo o aliviando los efectos causados por la obstruccion ureteral.This refers to a pharmaceutical composition in the form of capsules or tablets composed of the synergistic combination of various antispasmodic agents, such as the active ingredients: Floroglucinol and Trimethylfluoroglucinol and a non-steroidal anti-inflammatory agent, such as the active substance: Meloxicam, In addition to pharmaceutically acceptable excipients, which are formulated in a single dose unit to be administered orally, useful for the control and treatment of renal colic and inflammation caused by lithiasis, also achieving an effective control of pain as well It is to ensure that renal function is preserved by suppressing or relieving the effects caused by ureteral obstruction.

ARP080105130A 2007-11-26 2008-11-26 PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF VARIOUS ANTISPASMODIC AGENTS AND AN NON-STEROID ANTI-INFLAMMATORY AGENT, USEFUL FOR THE CONTROL AND TREATMENT OF RENAL COLICO AND INFLAMMATION AR071736A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2007014839A MX2007014839A (en) 2007-11-26 2007-11-26 Pharmaceutical composition combining various antispasmodic agents and a non-steroidal anti-inflammatory agent, which can be used to control and treat renal colic and inflammation.
PCT/MX2008/000160 WO2009069993A1 (en) 2007-11-26 2008-11-26 Pharmaceutical composition combining various antispasmodic agents and a non-steroidal anti-inflammatory agent, which can be used to control and treat renal colic and inflammation

Publications (1)

Publication Number Publication Date
AR071736A1 true AR071736A1 (en) 2010-07-14

Family

ID=40678781

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080105130A AR071736A1 (en) 2007-11-26 2008-11-26 PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF VARIOUS ANTISPASMODIC AGENTS AND AN NON-STEROID ANTI-INFLAMMATORY AGENT, USEFUL FOR THE CONTROL AND TREATMENT OF RENAL COLICO AND INFLAMMATION

Country Status (3)

Country Link
AR (1) AR071736A1 (en)
MX (1) MX2007014839A (en)
WO (1) WO2009069993A1 (en)

Also Published As

Publication number Publication date
MX2007014839A (en) 2009-05-26
WO2009069993A1 (en) 2009-06-04

Similar Documents

Publication Publication Date Title
ES2532849T3 (en) Treatment with melatonin agonist
EP2444072A3 (en) Non-mucoadhesive film dosage forms
AR085662A1 (en) METHODS AND COMPOSITIONS TO TREAT HYPERURICEMIA AND METABOLIC DISORDERS ASSOCIATED WITH HYPERURICEMIA
AR082803A1 (en) METHODS AND FORMULATIONS FOR THE TREATMENT OF THROMBOSIS WITH BETRIXABAN AND A GLICOPROTEIN P INHIBITOR
AR061166A1 (en) PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF PHENYLPHERINE
CO6220945A2 (en) USE OF A COMPOSITION THAT INCLUDES FORMOTEROL AND DIPROPIANATE OF BECLOMETASONE FOR THE PREVENTION AND / OR TREATMENT OF AN EXAMERATION OF ASTHMA
AR066666A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-CONVULSIVING AGENT
AR065139A1 (en) MEDICATION FOR THE TREATMENT OF ENDOMETRIOSIS
AR048806A1 (en) USE OF CARIOFILENES IN THE PREPARATION OF MEDICINES AND TREATMENT OF BODY INFLAMMATION AND INFLAMMATORY PAIN AFFECTIONS
AR075866A1 (en) A DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL DETERIORATION. USE. PHARMACEUTICAL COMPOSITION
RU2013105513A (en) Derivatives of 1-aminoalkylcyclohexane for the treatment of inflammatory skin diseases
CO6270220A2 (en) PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THE COMBINATION OF A NON-STEROID ANTIINFLAMOTORY AGENT AND AN INHIBITING AGENT OF THE XANTINO OXIDASE USEFUL FOR THE CONTROL AND TREATMENT OF THE DROP DROPPED ARTHRITIS AND RELATED DISEASES
AR074246A1 (en) DERIVATIVES OF 1-AMINO-ALQUILCICLOHEXANO FOR THE TREATMENT OF SOIL DISORDERS
AR071736A1 (en) PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF VARIOUS ANTISPASMODIC AGENTS AND AN NON-STEROID ANTI-INFLAMMATORY AGENT, USEFUL FOR THE CONTROL AND TREATMENT OF RENAL COLICO AND INFLAMMATION
AR067465A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A BENZISOXAZOLIC DERIVATIVE AGENT AND A BENZODIAZEPINIC AGENT
CO6241114A2 (en) PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF THE CIPROFLOXACINE ANTIMICROBIAL AGENT AND THE ASCORBIC ACID ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTION
AR067861A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVELY AGENT AND A BENZODIAZEPINIC AGENT, INDICATED FOR THE CONTROL AND TREATMENT OF CONVULSIVE DISORDERS AND EPILEPTIC SYNDROMES
AR066667A1 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE COMBINATION OF A HYDROGEN DERIVATIVE LIPSTATINE AGENT AND AN HMG COA REDUCTASA INHIBITING AGENT
CO6241103A2 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-CONVULSIVING AGENT
AR061046A1 (en) MIRTAZAPINE FOR THE TREATMENT OF NEUROPATHIC PAIN
AR047684A1 (en) COMPOSITIONS OF DECONGESTIVE OR ANTI-HISTAMINIC DRUGS AND NON-STEROID ANTI-INFLAMMATORIES
AR118056A2 (en) HISTONE DESACETILASE INHIBITOR FORMULATIONS IN COMBINATION WITH BENDAMUSTINE AND THE USE OF THE SAME
CO6260067A2 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING THE COMBINATION OF ACETACINE METOCARBAMOL AND DIACEREIN USEFUL IN THE TREATMENT OF ARTHRITIS AND REUMATOID T RELATED DISEASES
CO6260059A2 (en) PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF BETAMETOSONE (STEROID INFLAMMATORY AGENT) AND METOCARBAMOL (MUSCLE RELAXING) AND ITS USE IN THE TREATMENT OF MUSCLE SKELETIC DISEASES
AR066587A1 (en) DOSAGE FORM INCLUDING 10 - [(3S)) - 1-AZABICICLO [2.2.2] OCT-3 -ILMETIL] -10H-PHENOTIAZINE PROVIDED IN ADEQUATE FORM FOR ORAL ADMINISTRATION OF A DAILY DOSE OF 1 MG TO 3 MG

Legal Events

Date Code Title Description
FB Suspension of granting procedure